“…vary with regard to the uptake inhibitor and dose utilized as well as the duration of treatment and the withdrawal interval. However, chronic treatment with selective 5-HT uptake inhibitors (e.g., chlorimipramine, fluoxetine, fluvoxamine) generally decreased (Brunello et al, 1987;Hrdina, 1987;Montero et al, 1990) or had no effect (Marcusson et al, 1988) on L3Hlimipramine binding to crude synaptic preparations from rat brain. Similar repeated exposure to selective 5-HT uptake inhibitors, such as citalopram, indalpine, and zimelidine, decreased the sensitivity of 5-HT DR neurons to 5-HT and 5-HTIA autoreceptor agonists (Blier and de Montigny, 1983;Blier et al, 1984;1988;Chaput et al, 1986), although alterations in response to a 5-HT uptake inhibitor as described here has not yet been assessed.…”